CIP
PBYI icon

Chartwell Investment Partners’s Puma Biotechnology PBYI Stock Holding History

Chartwell Investment Partners’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-39,098
Closed -$3.87M – 424
2017
Q4 		$3.87M Sell
39,098
-3,742
-9% -$419K 0.13% 241
2017
Q3 		$5.13M Buy
42,840
+24,194
+130% +$2.25M 0.18% 186
2017
Q2 		$1.63M Buy
+18,646
New +$1.04M 0.06% 315
2015
Q2 		– Sell
-107,254
Closed -$25.3M – 327
2015
Q1 		$25.3M Buy
+107,254
New +$22.9M 0.49% 59

Other funds holding PBYI

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return